IR
46
3
SPG
45
2
DG
14
6
TMO
52
8
CMI
49
2
TGT
35
4
DTE
49
16
AMP
43
2
AMT
30
2
PHM
44
4
HPE
48
2
ADT
12
2
ETN
64
4
OMC
37
2
GIS
47
13
TRV
34
4
VMC
41
2
CHD
34
7
OI
23
3
SO
48
6
IR
46
3
SPG
45
2
DG
14
6
TMO
52
8
CMI
49
2
TGT
35
4
DTE
49
16
AMP
43
2
AMT
30
2
PHM
44
4
HPE
48
2
ADT
12
2
ETN
64
4
OMC
37
2
GIS
47
13
TRV
34
4
VMC
41
2
CHD
34
7
OI
23
3
SO
48
6
Financhill
Back

iShares Neuroscience and Healthcare ETF Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
6

IBRN
iShares Neuroscience and Healthcare ETF

Last Price:
$25.56
Seasonality Move:
-2.6%

7 Day Trial

ALL ACCESS PASS

$ 7

Elon Musk Predicts MAJOR Crisis in Trump's First Year

See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.

iShares Neuroscience and Healthcare ETF Stock Forecast

  • Over the next 52 weeks, iShares Neuroscience and Healthcare ETF has on average historically risen by 2.1% based on the past 2 years of stock performance.
  • iShares Neuroscience and Healthcare ETF has risen higher in 1 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is iShares Neuroscience and Healthcare ETF Stock Undervalued?
    The current iShares Neuroscience and Healthcare ETF [IBRN] share price is $25.37. The Score for IBRN is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
  • IBRN is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.

Will iShares Neuroscience and Healthcare ETF Stock Go Up Next Year?

  • Over the next 52 weeks, iShares Neuroscience and Healthcare ETF has on average historically risen by 2.1% based on the past 2 years of stock performance.

iShares Neuroscience and Healthcare ETF Stock Rating

Sell
6
iShares Neuroscience and Healthcare ETF (IBRN) is a Sell

Is iShares Neuroscience and Healthcare ETF overpriced?

  • iShares Neuroscience and Healthcare ETF has risen higher in 1 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

iShares Neuroscience and Healthcare ETF Stock Price History

Is IBRN stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IBRN is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NYSEARCA
Country:
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
28.74
52-Week Low:
22.67

Prediction Charts

Market Cap:
0
Price in USD:
25.37
Volume:
0
Beta:
0.72

Technical Analysis

SMA50:
26.87
SMA100:
25.97
SMA200:
25.12
52-Wk Change:
4.61%

Stock Predictions

  • Is iShares Neuroscience and Healthcare ETF stock public?
    Yes, iShares Neuroscience and Healthcare ETF is a publicly traded company.
  • What is the iShares Neuroscience and Healthcare ETF stock quote today?
    The iShares Neuroscience and Healthcare ETF stock price is 25.37 USD today.
  • How to buy iShares Neuroscience and Healthcare ETF stock online?
    You can buy iShares Neuroscience and Healthcare ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-3 26.70 26.61 26.75 26.61
Dec-4 26.80 26.85 26.85 26.80
Dec-5 26.44 26.46 26.49 26.44
Dec-6 26.46 26.46 26.46 26.46
Dec-9 26.46 26.46 26.46 26.46
Dec-10 26.46 26.46 26.46 26.46
Dec-11 26.46 26.46 26.46 26.46
Dec-12 26.02 25.90 26.02 25.90
Dec-13 25.90 25.90 25.90 25.90
Dec-16 26.49 26.47 26.49 26.47
Dec-17 26.16 26.20 26.20 26.16
Dec-18 26.20 26.20 26.20 26.20
Dec-19 25.10 25.37 25.37 25.10
Dec-20 25.37 25.37 25.37 25.37

iShares Neuroscience and Healthcare ETF Earnings

Data Unavailable

iShares Neuroscience and Healthcare ETF Forecast Revenue Growth

Data Unavailable

* iShares Neuroscience and Healthcare ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.